Cambrex plans to open new R&D manufacturing facility in Minneapolis, USA. It will be located near the Minneapolis–St. Paul Airport.
The project includes construction of new r&d facility and multi phase expansion.
The new r&d facility will be laid with an area covering of 21,000-square-foot to expand capacity for small molecule development and manufacturing. In addition, multi-phase, 9,000-square-foot expansion and a 21,000-square-foot renovation are also part of the project.
The exapnsion adds a new quality control laboratory and administrative office space. Moreover, the rennovation modernises the current quality control and research and development facilities.
The facility specialised in analytical and chemical process development for pharmaceutical drug candidates will be an extension for Cambrex’s flagship facility in Charles City, Iowa. The new R & D facility is expected to add 40 new jobs in the coming 2-3 years.